The Gram-negative pathogen Helicobacter pylori is increasingly more resistant to the three major antibiotics (metronidazole, clarithromycin and amoxicillin) that are most commonly used to treat infection. As a result, there is an increased rate of treatment failure; this translates into an overall higher cost of treatment due to the need for increased length of treatment and/or the requirement for combination or sequential
therapy. Given the rise in antibiotic resistance, the complicated treatment regime, and issues related to patient compliance that stem from the duration and complexity of treatment, there is clearly a pressing need for the development of novel therapeutic strategies to combat H. pylori infection. As such, researchers are actively investigating the utility of antimicrobial peptides, small molecule inhibitors and naturopathic therapies. Herein we review and discuss each of these novel approaches as a means to target this important gastric pathogen.
Citations
Citations to this article as recorded by
Pistacia vera L. as natural source against antimicrobial and antiviral resistance Giuseppina Mandalari, Rosamaria Pennisi, Teresa Gervasi, Maria Teresa Sciortino Frontiers in Microbiology.2024;[Epub] CrossRef
Efficacy of a standardised herbal formulation in Helicobacter pylori positive patients with gastritis or peptic ulcer: a triple-blind randomised clinical trial Arefe Shojaeian, Alireza Khalilian, Maryam Mehrpoya, Jalal Poorolajal, Dara Dastan Journal of Herbal Medicine.2023; 41: 100706. CrossRef
Antibacterial, Antibiofilm, and Antioxidant Activity of 15 Different Plant-Based Natural Compounds in Comparison with Ciprofloxacin and Gentamicin Ali Pormohammad, Dave Hansen, Raymond J. Turner Antibiotics.2022; 11(8): 1099. CrossRef
Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning Study Federico Antoniciello, Davide Roncarati, Annamaria Zannoni, Elena Chiti, Vincenzo Scarlato, Federica Chiappori Frontiers in Molecular Biosciences.2022;[Epub] CrossRef
Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa Chun-Yan Weng, Jing-Li Xu, Shao-Peng Sun, Kai-Jie Wang, Bin Lv World Journal of Gastroenterology.2021; 27(31): 5152. CrossRef
A Comprehensive Study on the Antimicrobial Properties of Resveratrol as an Alternative Therapy Ehsan Abedini, Ehsaneh Khodadadi, Elham Zeinalzadeh, Seyyed Reza Moaddab, Mohammad Asgharzadeh, Bahareh Mehramouz, Sounkalo Dao, Hossein Samadi Kafil, Weicheng Hu Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1. CrossRef
Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice Patrícia C. Henriques, Lia M. Costa, Catarina L. Seabra, Bernardo Antunes, Ricardo Silva-Carvalho, Susana Junqueira-Neto, André F. Maia, Pedro Oliveira, Ana Magalhães, Celso A. Reis, Fátima Gartner, Eliette Touati, Joana Gomes, Paulo Costa, M. Cristina L. Acta Biomaterialia.2020; 114: 206. CrossRef
Effects of cinnamon extract on complications of treatment and eradication of Helicobacter pylori in infected people Ghazal Imani, Alireza khalilian, Dara Dastan, Behzad Imani, Maryam Mehrpoya Journal of Herbmed Pharmacology.2020; 9(1): 55. CrossRef
Flacourtia indica based biogenic nanoparticles: development, characterization, and bioactivity against wound associated pathogens Farooq Ahmad, Muhammad Babar Taj, Muhammad Ramzan, Ahmad Raheel, Saima Shabbir, Muhammad Imran, Hafiz M N Iqbal Materials Research Express.2020; 7(1): 015026. CrossRef
In vitro activity of neem (Azadirachta indica) oil extract against Helicobacter pylori Faith C. Blum, Jatinder Singh, D. Scott Merrell Journal of Ethnopharmacology.2019; 232: 236. CrossRef
Study of inhibitory effects of the mixture of cinnamon and ginger extracts on cagA gene expression of Helicobacter pylori by Real-Time RT-PCR technique Morteza Azadi, Asa Ebrahimi, Azad Khaledi, Davoud Esmaeili Gene Reports.2019; 17: 100493. CrossRef
In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong Gut and Liver.2017; 11(5): 648. CrossRef
Helicobacter pylori treatment: New perspectives using current experience Amin Talebi Bezmin Abadi Journal of Global Antimicrobial Resistance.2017; 8: 123. CrossRef
Selective killing of
Helicobacter pylori
with pH-responsive helix–coil conformation transitionable antimicrobial polypeptides
Menghua Xiong, Yan Bao, Xin Xu, Hua Wang, Zhiyuan Han, Zhiyu Wang, Yeqing Liu, Songyin Huang, Ziyuan Song, Jinjing Chen, Richard M. Peek, Lichen Yin, Lin-Feng Chen, Jianjun Cheng Proceedings of the National Academy of Sciences.2017; 114(48): 12675. CrossRef
Helicobacter pylori outer membrane protein, HomC, shows geographic dependent polymorphism that is influenced by the Bab family Aeryun Kim, Stephanie L. Servetas, Jieun Kang, Jinmoon Kim, Sungil Jang, Yun Hui Choi, Hanfu Su, Yeong-Eui Jeon, Youngmin A. Hong, Yun-Jung Yoo, D. Scott Merrell, Jeong-Heon Cha Journal of Microbiology.2016; 54(12): 846. CrossRef
Morphological changes in human gastric epithelial cells induced by nuclear targeting of Helicobacter pylori urease subunit A Jung Hwa Lee, So Hyun Jun, Jung-Min Kim, Seung Chul Baik, Je Chul Lee Journal of Microbiology.2015; 53(6): 406. CrossRef
Dietary amelioration of Helicobacter infection Jed W. Fahey, Katherine K. Stephenson, Alison J. Wallace Nutrition Research.2015; 35(6): 461. CrossRef
Antibiotic treatment forHelicobacter pylori: Is the end coming? Su Young Kim World Journal of Gastrointestinal Pharmacology and Therapeutics.2015; 6(4): 183. CrossRef
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection Inês C Gonçalves, Patrícia C Henriques, Catarina L Seabra, M Cristina L Martins Expert Review of Anti-infective Therapy.2014; 12(8): 981. CrossRef